CPHI [CHINA PHARMAS,] 10-Q/A: FORM 10-Q/A (Amendment No. 1) (Mark One) x
[FORM 10-Q/A (Amendment No. 1) (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216] [CERTIFICATION I, Zhilin Li, certify that: 1. I have reviewed this Amendment No. 1 to Form 10-Q for the quarter ended September 30, 2010 of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this Amendment No. 1 on Form 10-Q for the quarter ended September 30, 2010 of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:March 15, 2011 -------------------------------- President and Chief Executive Officer cphi10qaex321093010.htm 4 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:March 15, 2011 --------------------- (principal financial officer and principal accounting officer) cphi10qaex322093010.htm 5 EX-32.2]